pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
(metformin hydrochloride + pioglitazone hydrochloride)
Actoplus Met ((metformin hydrochloride + pioglitazone hydrochloride))
Type 2 Diabetes
Takeda Pharmaceuticals USA Inc
0 catalysts
Marketed
(metformin hydrochloride + saxagliptin) ER
Metformin Hydrochloride + Saxagliptin Hydrochloride ((metformin hydrochloride + saxagliptin))
Type 2 Diabetes
Dr. Reddy's Laboratories Ltd
0 catalysts
Marketed
(metformin hydrochloride + sitagliptin phosphate) ER
Janumet XR ((metformin hydrochloride + sitagliptin phosphate))
Type 2 Diabetes
Merck Sharp & Dohme LLC
catalysts
← prev
page 44 of 231
next →
131
Pain89
Neurology1
0
Marketed
(metformin hydrochloride + sitagliptin) ER
Zituvimet XR ((metformin hydrochloride + sitagliptin))
Type 2 Diabetes
Zydus Pharmaceuticals USA Inc
0 catalysts
Marketed
(methyl salicylate + menthol)
Salonpas (methyl salicylate [INN])
Arthritis Pain
Hisamitsu America Inc
0 catalysts
Phase 2
(methylprednisolone + zoledronic acid)
Osteoarthritis
Levolta Pharmaceuticals Inc
0 catalysts
Phase 2
(minoxidil + finasteride + latanoprost)
Androgenic Alopecia
Triple Hair Inc
0 catalysts
Marketed
(mometasone furoate + olopatadine hydrochloride)
Ryaltris ((mometasone furoate + olopatadine hydrochloride))
Seasonal Allergic Rhinitis
Hikma Pharmaceuticals USA Inc
0 catalysts
Preclinical
(naloxone + flumazenil)
(naloxone [INN]+ flumazenil)
Acute Opioid Overdosage
Mesox Ltd
0 catalysts
Marketed
(naloxone hydrochloride + pentazocine hydrochloride)
Pentazocine Hydrochloride + Naloxone Hydrochloride ((naloxone hydrochloride + pentazocine hydrochloride))
Pain
Gavis Pharmaceuticals LLC
0 catalysts
Phase 2
(nanatinostat + valganciclovir)
(nanatinostat + valganciclovir [INN])
Post-Transplant Lymphoproliferative Disorder
Viracta Therapeutics Inc
0 catalysts
Marketed
(naphazoline + pheniramine maleate)
Naphazoline Hydrochloride + Pheniramine Maleate ((naphazoline [INN] + pheniramine maleate))
Allergic Conjunctivitis
Altaire Pharmaceuticals Inc
0 catalysts
Marketed
(naproxen sodium + pseudoephedrine hydrochloride) ER
Naproxen Sodium + Pseudoephedrine Hydrochloride ((naproxen sodium + pseudoephedrine hydrochloride))
Acute Bacterial Sinusitis
L. Perrigo Company
0 catalysts
Marketed
(naproxen sodium + sumatriptan succinate)
Treximet ((naproxen sodium + sumatriptan succinate))
Migraine
Currax Pharmaceuticals LLC
0 catalysts
Marketed
(nebivolol hydrochloride + valsartan)
Vyduo ((nebivolol hydrochloride + valsartan))
Hypertension
Prinston Pharmaceutical Inc
0 catalysts
Phase 3
(neltependocel + Y-27632)
Vyznova (neltependocel [INN])
Corneal Edema
Aurion Biotech Inc
0 catalysts
Marketed
(neomycin sulfate + polymyxin B)
Neomycin + Polymyxin B Sulfate ((neomycin sulfate + polymyxin B [INN]))
Bacteriuria
X-GEN Pharmaceuticals DJB Inc
0 catalysts
Marketed
(nivolumab + relatlimab)
Opdualag ((nivolumab + relatlimab-rmbw))
Metastatic Melanoma
Bristol-Myers Squibb Co
0 catalysts
Marketed
(nystatin + triamcinolone acetonide)
Nystatin + Triamcinolone Acetonide ((nystatin [INN] + triamcinolone acetonide))
Candidiasis
Crown Laboratories Inc
0 catalysts
Marketed
(olodaterol hydrochloride + tiotropium bromide)
Stiolto Respimat ((olodaterol hydrochloride + tiotropium bromide))
Chronic Bronchitis
Boehringer Ingelheim Corp
0 catalysts
Marketed
(omeprazole + sodium bicarbonate)
Zegerid ((omeprazole + sodium bicarbonate))
Acid Indigestion (Heartburn/Pyrosis)
Salix Pharmaceuticals Ltd
0 catalysts
Marketed
(oxymetazoline hydrochloride + tetracaine hydrochloride)
Kovanaze ((oxymetazoline hydrochloride + tetracaine hydrochloride))
Anesthetic Effect
St Renatus LLC
0 catalysts
pre_registration
(pegadricase + sirolimus)
Gouty Arthritis (Gout)
Swedish Orphan Biovitrum AB
0 catalysts
Marketed
(penicillin G benzathine + penicillin G procaine)
Bicillin C-R ((penicillin G benzathine + penicillin G procaine))
Bacteremia
$PFEPFIZER INC
0 catalysts
Marketed
(phenylephrine hydrochloride + promethazine)
Prometh VC Plain ((phenylephrine hydrochloride + promethazine [INN]))
Allergic Rhinitis
G&W Laboratories Inc
0 catalysts
Marketed
(piperacillin sodium + tazobactam sodium)
Piperacillin Sodium + Tazobactam Sodium ((piperacillin sodium + tazobactam sodium))
Community-Acquired Bacterial Pneumonia
Milla Pharmaceuticals Inc
0 catalysts
Phase 2
(plerixafor + tacrolimus)
Wounds
MedRegen LLC
0 catalysts
Marketed
(polymyxin B + trimethoprim sulfate)
Polymyxin B + Trimethoprim Sulfate Pacific ((polymyxin B [INN] + trimethoprim sulfate))
Bacterial Conjunctivitis
Pacific Pharmaceuticals USA
0 catalysts
pre_registration
(potassium bicarbonate + potassium citrate) PR
Sibnayal ((potassium bicarbonate [USP] + potassium citrate [USP]))
Kidney Disease (Nephropathy)
Advicenne SA
0 catalysts
Marketed
(potassium phosphate dibasic + potassium phosphate monobasic)
Potassium Phosphates (POTASSIUM PHOSPHATES)
Hypophosphatemia
Hospira Inc
0 catalysts